1. Home
  2. LDI vs TKNO Comparison

LDI vs TKNO Comparison

Compare LDI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo loanDepot Inc.

LDI

loanDepot Inc.

HOLD

Current Price

$2.16

Market Cap

954.8M

Sector

Finance

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$4.19

Market Cap

236.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LDI
TKNO
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
954.8M
236.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LDI
TKNO
Price
$2.16
$4.19
Analyst Decision
Sell
Analyst Count
3
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
3.9M
122.3K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,095,780,000.00
$39,801,000.00
Revenue This Year
$24.99
$8.79
Revenue Next Year
$18.02
$10.52
P/E Ratio
N/A
N/A
Revenue Growth
10.74
9.50
52 Week Low
$1.01
$3.85
52 Week High
$5.05
$10.37

Technical Indicators

Market Signals
Indicator
LDI
TKNO
Relative Strength Index (RSI) 35.81 34.82
Support Level $2.11 $4.02
Resistance Level $2.88 $4.86
Average True Range (ATR) 0.15 0.29
MACD -0.04 -0.05
Stochastic Oscillator 8.39 23.85

Price Performance

Historical Comparison
LDI
TKNO

About LDI loanDepot Inc.

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: